COVID-19 Antigen Lateral Flow Assay

The COVID-19 Antigen Lateral Flow Assay is a lateral flow immunoassay intend for the qualitative detection SARS-CoV-2 nucleocapsid protein antigens in nasopharyngeal swab and oropharyngeal swab from individuals who are suspected of COVID-19 by their healthcare provider. Equipped with most consumables needed, it is rapid, accurate, cost-effective and user-friendly.

Characteristics

• Name: COVID-19 Antigen Lateral Flow Assay
• Method: Lateral Flow Assay
• Sample type: Nasopharyngeal swab, oropharyngeal swab
• Specification: 20 tests/kit
• Detection time: 15 min
• Detection objects: COVID-19
• Stability: The kit is stable for 1 year at 2-30°C

Advantage

• Rapid: Obtain result within 15 min
• Intuitive result: There is no need for calculation, visual reading result
• Economic: Product can be transported and stored at room temperature, reducing costs